参考文献/References:
[1] 殷蔚伯, 余子豪, 徐国镇, 等. 肿瘤放射治疗学(第四版)[M]. 北京:中国协和医科大学出版社, 2008:1200.
[2] 郭阳, 姜炜, 张文学, 等. 立体定向放射治疗脑转移瘤疗效分析[J]. 国际放射医学核医学杂志. 2007, 31(2):122-124.
[3] Eichler AF, Loeffler JS. Multidisciplinary management of brain Metastases[J]. Oncologist, 2007, 12(7):884-898.
[4] Borgelt B, Gelber R, Kramer S, et al. The palliation of brain metas-tases:final results of the first two studies by the Radiation Therapy Oncology Group[J]. Int J Radiat Oncol Biol Phys, 1980, 6(1):1-9.
[5] Deangelis LM, Delattre JY, Posner JB. Radiation-induced dementia in patients cured of brain metastases[J]. Neurology, 1989, 39(6):789-796.
[6] Meyer A, Steinmann D, Malaimare L, et al. Prediction of prognosis regarding fractionation schedule and survival in patients with whole-brain radiotherapy for metastatic disease[J]. Anticancer Res, 2009, 28(6B):3965-3969.
[7] Tsao MN, Lloyd N, Wong RK, et al. Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases[J/OL]. Cochrane Database Syst Rev, 2012, 4:CD003869[2015-03-29]. http://www.ncbi.nlm.nih.gov/pubmed/22513917.
[8] Lee YW, Cho HJ, Lee WH, et al. Whole brain radiation-induced cognitive impairment:pathophysiological mechanisms and thera-peutic targets[J]. Biomol Ther(Seoul), 2012, 20(4):357-370.
[9] Gondi V, Hermann BP, Mehta MP, et al. Hippocampal dosimetry predicts neurocognitive function impairment after fractionated stereotactic radiotherapy for benign or low-grade adult brain tumors[J/OL]. Int J Radiat Oncol Biol Phys, 2012, 83(4):e487-e493[2015-03-29]. http://www.ncbi.nlm.nih.gov/pubmed/22209148.
[10] Gondi V, Pugh SL, Tome WA, et al. Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compart-ment during whole-brain radiotherapy for brain metastases (RTOG 0933):a phase Ⅱ multi-institutional trial[J]. J Clin Oncol, 2014, 32(34):3810-3816.
[11] Harth S, Abo-Madyan Y, Zheng L, et al. Estimation of intracranial failure risk following hippocampal-sparing whole brain radiothera-py[J]. Radiother Oncol, 2013, 109(1):152-158.
[12] Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiothera-py in the treatment of single metastases to the brain:a randomized trial[J]. JAMA, 1998, 280(17):1485-1489.
[13] Mcpherson CM, Suki D, Feiz-Erfan I, et al. Adjuvant whole-brain radiation therapy after surgical resection of single brain metastases[J]. Neuro Oncol, 2010, 12(7):711-719.
[14] Gaspar LE, Mehta MP, Patchell RA, et al. The role of whole brain radiation therapy in the management of newly diagnosed brain metastases:a systematic review and evidence-based clinical prac-tice guideline[J]. J Neurooncol, 2010, 96(1):17-32.
[15] Stark AM, St?hring C, Hedderich J, et al. Surgical treatment for brain metastases:Prognostic factors and survival in 309 patients with regard to patient age[J]. J Clin Neurosci, 2011, 18(1):34-38.
[16] Sanghavi SN, Miranpuri SS, Chappell R, et al. Radiosurgery for pa-tients with brain metastases:a multi-institutional analysis, strati-fied by the RTOG recursive partitioning analysis method[J]. Int J Radiat Oncol Biol Phys, 2001, 51(2):426-434.
[17] Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases:phase Ⅲ results of the RTOG 9508 randomised trial[J]. Lancet, 2004, 363(9422):1665-1672.
[18] Assouline A, Levy A, Chargari C, et al. Whole brain radiotherapy:prognostic factors and results of a radiation boost delivered through a conventional linear accelerator[J]. Radiother Oncol, 2011, 99(2):214-217.
[19] Bauman G, Yartsev S, Fisher B, et al. Simultaneous infield boost with helical tomotherapy for patients with 1 to 3 brain metastases[J]. Am J Clin Oncol, 2007, 30(1):38-44.
[20] Rodrigues G, Yartsev S, Yaremko B, et al. Phase I trial of simulta-neous in-field boost with helical tomotherapy for patients with one to three brain metastases[J]. Int J Radiat Oncol Biol Phys, 2011, 80(4):1128-1133.
[21] Zhou L, Liu J, Xue J, et al. Whole brain radiotherapy plus simulta-neous in-field boost with image guided intensity-modulated radio-therapy for brain metastases of non-small cell lung cancer[J/OL]. Radiat Oncol, 2014, 9:117[2015-03-29]. http://www.ncbi.nlm.nih.gov/pubmed/24884773.
[22] Bindal AK, Bindal RK, Hess KR, et al. Surgery versus radiosurgery in the treatment of brain metastasis[J]. J Neurosurg, 1996, 84(5):748-754.
[23] Sch?ggl A, Kitz K, Reddy M, et al. Defining the role of stereotactic radiosurgery versus microsurgery in the treatment of single brain metastases[J]. Acta Neurochir(Wien), 2000, 142(6):621-626.
[24] Choi CY, Chang SD, Gibbs IC, et al. Stereotactic radiosurgery of the postoperative resection cavity for brain metastases:prospective evaluation of target margin on tumor control[J]. Int J Radiat On-col Biol Phys, 2012, 84(2):336-342.
[25] Aoyama H, Shirato H, Tago M, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases:a randomized controlled trial[J]. JAMA, 2006, 295(21):2483-2491.
[26] Kocher M, Soffietti R, Abacioglu U, et al. Adjuvant whole-brain ra-diotherapy versus observation after radiosurgery or surgical resec-tion of one to three cerebral metastases:results of the EORTC 22952-26001 study[J]. J Clin Oncol, 2011, 29(2):134-141.
[27] Rades D, Huttenlocher S, Hornung D, et al. Do patients with very few brain metastases from breast cancer benefit from whole-brain radiotherapy in addition to radiosurgery?[J/OL]. Radiat Oncol, 2014, 9:267[2015-03-29]. http://www.ncbi.nlm.nih.gov/pubmed/25472758.
相似文献/References:
[1]李景涛,邓垒,张文珏,等.广泛期小细胞肺癌胸部IMRT后发生放射性肺炎的危险因素分析[J].国际放射医学核医学杂志,2016,40(2):100.[doi:10.3760/cma.j.issn.1673-4114.2016.02.003]
Li Jingtao,Deng Lei,Zhang Wenjue,et al.Risk factor analysis for predicting radiation pneumonitis in extensive stage small cell lung cancer patients receiving IMRT thoracic radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):100.[doi:10.3760/cma.j.issn.1673-4114.2016.02.003]
[2]刘佳,高刚,朴春南,等.调节肿瘤放射敏感性的miRNAs研究进展[J].国际放射医学核医学杂志,2016,40(2):159.[doi:10.3760/cma.j.issn.1673-4114.2016.02.015]
Liu Jia,Gao Gang,Piao Chunnan,et al.Progress of microRNAs in regulating tumor radiation sensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):159.[doi:10.3760/cma.j.issn.1673-4114.2016.02.015]
[3]陈晓艳,张江虹,邵春林.STAT3与辐射敏感相关性的研究进展[J].国际放射医学核医学杂志,2016,40(3):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
Chen Xiaoyan,Jianghong,Shao Chunlin.Research progresses of correlation between STAT3 and radiosensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
[4]赵德云,李百龙.植物提取物防治放射性肺损伤的现状与展望[J].国际放射医学核医学杂志,2016,40(3):208.[doi:10.3760/cma.j.issn.1673-4114.2016.03.010]
Zhao Deyun,Li Bailong.Protective and therapeutic effects of plant extracts on radiation-induced lung injury:present status and future prospects[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):208.[doi:10.3760/cma.j.issn.1673-4114.2016.03.010]
[5]田琦,蒋宁一,郑丽.265例精细个体化131I治疗Graves甲亢的疗效观察[J].国际放射医学核医学杂志,2016,40(4):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
Tian Qi,Jiang Ningyi,Zheng Li.Therapeutic effect of fine individual 131I treatment on Graves disease hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
[6]赵舒怡,储小飞,樊赛军.血清肿瘤标志物与肿瘤放疗疗效评估的研究进展[J].国际放射医学核医学杂志,2015,39(5):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
zhao shuyi,chu xiaofei,fan saijun..progression of study on serum tumor markers in evaluation of tumor radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
[7]赵徵鑫,翟贺争,张文艺,等.质子重离子治疗肿瘤的进展[J].国际放射医学核医学杂志,2016,40(5):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
Zhao Zhixin,Zhai Hezheng,Zhang Wenyi,et al.Development of proton heavy ion in tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
[8]段永璇,邹晓艳,段秀梅,等.数据解析在肿瘤放射治疗中的应用[J].国际放射医学核医学杂志,2015,39(6):505.[doi:10.3760/cma.j.issn.1673-4114.2015.06.015]
Duan Yongxuan,Zou Xiaoyan,Duan Xiumei,et al.Data analysis in the field of tumor radiation therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):505.[doi:10.3760/cma.j.issn.1673-4114.2015.06.015]
[9]贾立立,孟粹达,刘晓冬,等.头颈部肿瘤放疗中转化医学相关机制的研究进展[J].国际放射医学核医学杂志,2015,39(3):247.[doi:10.3760/cma.j.issn.1673-4114.2015.03.013]
Jia Lili,Meng Cuida,Liu Xiaodong,et al.Development in translational medicine-related mechanisms of radiotherapy for head and neck cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):247.[doi:10.3760/cma.j.issn.1673-4114.2015.03.013]
[10]曹婉婷,李浣洋,陈雪英,等.正常组织在放射治疗中并发的迟发性损伤[J].国际放射医学核医学杂志,2015,39(3):260.[doi:10.3760/cma.j.issn.1673-4114.2015.03.016]
Cao Wanting,Li Huanyang,Chen Xueying,et al.Late effects of radiotherapy on normal tissue[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):260.[doi:10.3760/cma.j.issn.1673-4114.2015.03.016]
[11]邓大平,卢峰,孙洪强,等.颅脑肿瘤放射治疗时射野外器官吸收剂量体模法测量与分析[J].国际放射医学核医学杂志,2016,40(4):272.[doi:10.3760/cma.j.issn.1673-4114.2016.04.007]
Deng Daping,Lu Feng,Sun Hongqiang,et al.Test and analysis of out-of-field organ dose in intracranial tumor radiotherapy using phantom[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):272.[doi:10.3760/cma.j.issn.1673-4114.2016.04.007]
[12]姜炜.颅内生殖细胞瘤的放射治疗[J].国际放射医学核医学杂志,2006,30(6):362.
JIANG Wei.Radiotherapy for intracranial germinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(4):362.
[13]陈跃.颅内肿瘤放射治疗后18F-氟代脱氧葡萄糖PET的临床意义[J].国际放射医学核医学杂志,2006,30(2):97.
CHEN Yue.Clinical value of 18F-FDG PET after radiotherapy for intracerebral tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(4):97.